HuGE Literature Finder
Records 1-26
|
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
International journal of cancer 2018 Oct 143 (8): 1935-1942. Fan Cong, Zhang Juan, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
|
Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
Breast cancer (Tokyo, Japan) 2018 May 25 (3): 350-355. Khan Rabbia Tariq, Siddique Ayesha, Shahid Naeem, Khokher Samina, Fatima War |
|
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
|
Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.
Carcinogenesis 2017 05 38 (5): 511-518. Han Mi-Ryung, Zheng Wei, Cai Qiuyin, Gao Yu-Tang, Zheng Ying, Bolla Manjeet K, Michailidou Kyriaki, Dennis Joe, Wang Qin, Dunning Alison M, Brennan Paul, Chen Shou-Tung, Choi Ji-Yeob, Hartman Mikael, Ito Hidemi, Lophatananon Artitaya, Matsuo Keitaro, Miao Hui, Muir Kenneth, Sangrajrang Suleeporn, Shen Chen-Yang, Teo Soo Hwang, Tseng Chiu-Chen, Wu Anna H, Yip Cheng Har, Kang Daehee, Xiang Yong-Bing, Easton Douglas F, Shu Xiao-Ou, Long Jiro |
|
Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Breast cancer research and treatment 2017 01 161 (1): 95-102. Kim Haeyoung, Cho Dae-Yeon, Choi Doo Ho, Oh Mijin, Shin Inkyung, Park Won, Huh Seung Jae, Nam Seok Jin, Lee Jeong Eon, Kim Seok W |
|
Whole-exome sequencing of Finnish hereditary breast cancer families.
European journal of human genetics : EJHG 2016 Oct . Määttä Kirsi, Rantapero Tommi, Lindström Anna, Nykter Matti, Kankuri-Tammilehto Minna, Laasanen Satu-Leena, Schleutker Johan |
|
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
Oncotarget 2016 Jan . Lin Po-Han, Kuo Wen-Hung, Huang Ai-Chu, Lu Yen-Shen, Lin Ching-Hung, Kuo Sung-Hsin, Wang Ming-Yang, Liu Chun-Yu, Cheng Fiona Tsui-Fen, Yeh Ming-Hsin, Li Huei-Ying, Yang Yu-Hsuan, Hsu Yu-Hua, Fan Sheng-Chih, Li Long-Yuan, Yu Sung-Liang, Chang King-Jen, Chen Pei-Lung, Ni Yen-Hsuan, Huang Chiun-She |
|
A Comparative Analysis of Breast and Ovarian Cancer-related Gene Mutations in Canadian and Saudi Arabian Patients with Breast Cancer.
Anticancer research 2015 May 35 (5): 2601-10. Amemiya Yutaka, Bacopulos Stephanie, Al-Shawarby Mohamed, Al-Tamimi Dalal, Naser Walid, Ahmed Ayesha, Khalifa Mahmoud, Slodkowska Elzbieta, Seth Ar |
|
Targeted Resequencing of 30 Genes Improves the Detection of Deleterious Mutations in South Indian Women with Breast and/or Ovarian Cancers.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (13): 5211-7. Rajkumar Thangarajan, Meenakumari Balaiah, Mani Samson, Sridevi Veluswami, Sundersingh Shirl |
|
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
European journal of human genetics : EJHG 2014 Nov 22 (11): 1305-13. Castéra Laurent, Krieger Sophie, Rousselin Antoine, Legros Angélina, Baumann Jean-Jacques, Bruet Olivia, Brault Baptiste, Fouillet Robin, Goardon Nicolas, Letac Olivier, Baert-Desurmont Stéphanie, Tinat Julie, Bera Odile, Dugast Catherine, Berthet Pascaline, Polycarpe Florence, Layet Valérie, Hardouin Agnes, Frébourg Thierry, Vaur Dominiq |
|
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Breast cancer research : BCR 2014 16 (3): R58. Damiola Francesca, Pertesi Maroulio, Oliver Javier, Le Calvez-Kelm Florence, Voegele Catherine, Young Erin L, Robinot Nivonirina, Forey Nathalie, Durand Geoffroy, Vallée Maxime P, Tao Kayoko, Roane Terrell C, Williams Gareth J, Hopper John L, Southey Melissa C, Andrulis Irene L, John Esther M, Goldgar David E, Lesueur Fabienne, Tavtigian Sean |
|
Haplotype analysis of eight genes of the monoubiquitinated FANCD2-DNA damage-repair pathway in breast cancer patients.
Cancer epidemiology 2013 Jun 37 (3): 311-7. Tang Li-Li, Chen Fei-Yu, Wang Hao, Hu Xue-Li, Dai Xu, Mao Jie, Shen Zheng-Tang, Wu Yu-Hui, Wang Shou-Man, Hai Jian, Yan Guo-Jiao, Li Hui, Huang Ju |
|
RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.
Breast cancer research and treatment 2012 May 133 (1): 111-6. He Min, Di Gen-Hong, Cao A-Yong, Hu Zhen, Jin Wei, Shen Zhen-Zhou, Shao Zhi-Mi |
|
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Human mutation 2012 Jan 33 (1): 158-64. Brooks Jennifer D, Teraoka Sharon N, Reiner Anne S, Satagopan Jaya M, Bernstein Leslie, Thomas Duncan C, Capanu Marinela, Stovall Marilyn, Smith Susan A, Wei Shan, Shore Roy E, Boice John D, Lynch Charles F, Mellemkjaer Lene, Malone Kathleen E, Liang Xiaolin, , Haile Robert W, Concannon Patrick, Bernstein Jonine |
|
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.
Cancer research 2011 Sep 71 (17): 5792-805. Rebbeck Timothy R, Mitra Nandita, Domchek Susan M, Wan Fei, Friebel Tara M, Tran Teo V, Singer Christian F, Tea Muy-Kheng Maria, Blum Joanne L, Tung Nadine, Olopade Olufunmilayo I, Weitzel Jeffrey N, Lynch Henry T, Snyder Carrie L, Garber Judy E, Antoniou Antonis C, Peock Susan, Evans D Gareth, Paterson Joan, Kennedy M John, Donaldson Alan, Dorkins Huw, Easton Douglas F, , Rubinstein Wendy S, Daly Mary B, Isaacs Claudine, Nevanlinna Heli, Couch Fergus J, Andrulis Irene L, Freidman Eitan, Laitman Yael, Ganz Patricia A, Tomlinson Gail E, Neuhausen Susan L, Narod Steven A, Phelan Catherine M, Greenberg Roger, Nathanson Katherine |
|
Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.
Breast cancer research and treatment 2011 Jan 125 (1): 207-14. Monsees Genevieve M, Kraft Peter, Chanock Stephen J, Hunter David J, Han Jia |
|
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Breast cancer research : BCR 2011 13 (1): R20. Kuusisto Kirsi M, Bebel Aleksandra, Vihinen Mauno, Schleutker Johanna, Sallinen Satu-Lee |
|
RAD50 gene mutations are not likely a risk factor for breast cancer in Poland.
Breast cancer research and treatment 2010 Sep 123 (2): 607-9. Mosor Maria, Zió?kowska-Suchanek Iwona, Roznowski Krzysztof, Baranowska Marta, Januszkiewicz-Lewandowska Danuta, Nowak Jer |
|
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.
Breast cancer research and treatment 2010 May 121 (1): 147-56. Loizidou Maria A, Cariolou Marios A, Neuhausen Susan L, Newbold Robert F, Bashiardes Evy, Marcou Yiola, Michael Thalia, Daniel Maria, Kakouri Eleni, Papadopoulos Panayiotis, Malas Simon, Hadjisavvas Andreas, Kyriacou Kyriac |
|
Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer.
Breast cancer research and treatment 2010 May 121 (1): 247-9. Cao A-Yong, Hu Zhen, Yin Wen-Jin, Jin Wei, Shao Zhi-Mi |
|
Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Feb 18 (2): 684-5. Uhrhammer Nancy, Delort Laetitia, Bignon Yves-Je |
|
Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Jan 18 (1): 255-9. Mavaddat Nasim, Dunning Alison M, Ponder Bruce A J, Easton Douglas F, Pharoah Paul |
|
Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
Gynecologic oncology 2009 Jan 112 (1): 210-4. Vega Ana, Salas Antonio, Milne Roger L, Carracedo Begoña, Ribas Gloria, Ruibal Alvaro, de León Antonio Cabrera, González-Hernández Ana, Benítez Javier, Carracedo Ang |
|
Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Dec 17 (12): 3482-9. Pooley Karen A, Baynes Caroline, Driver Kristy E, Tyrer Jonathan, Azzato Elizabeth M, Pharoah Paul D P, Easton Douglas F, Ponder Bruce A J, Dunning Alison |
|
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Oct 16 (10): 2024-32. Hsu Huan-Ming, Wang Hui-Chun, Chen Sou-Tong, Hsu Giu-Cheng, Shen Chen-Yang, Yu Jyh-Cher |
|
Evaluation of RAD50 in familial breast cancer predisposition.
International journal of cancer. Journal international du cancer 2006 Jun 118 (11): 2911-6. Tommiska Johanna, Seal Sheila, Renwick Anthony, Barfoot Rita, Baskcomb Linda, Jayatilake Hiran, Bartkova Jirina, Tallila Jonna, Kaare Milja, Tamminen Anitta, Heikkilä Päivi, Evans D Gareth, Eccles Diana, Aittomäki Kristiina, Blomqvist Carl, Bartek Jiri, Stratton Michael R, Nevanlinna Heli, Rahman Nazne |
- Page last reviewed:Jul 30, 2019
- Page last updated:Jan 23, 2020
- Content source: